Selection and Transplantation of Autologous Hematopoietic CD34⁺ Cells for Patients with Multiple Myeloma

References

• Attal M., Haronsseeau J. L., Stoppa A. M., Sotto J. L., Fuzibet G., Rossi J. F., Casassus P., Thyss A., Maisonneuve H., Facon T., Ifrah N., Riyen C., Bataillc K. High-dose thci-apy in multiple niyclom:i: A prospective randomized study of the “Intergroupe francais du myelome” (IFM). Blood 1994; 84: 386a, (abstr.)
   Web of Science ®Google Scholar
• To L. B. Is our current strategy in manipulaling hemopoiesis in autologous transplantation correct?. Stem Cells 1993; 11: 283–289
   PubMedGoogle Scholar
• Fermand J. P., Chevert S., Ravaud P., Divine M., Leblond V., Dreyfus F., Mariette X., Brouet J. C. High dose chemoradiotherapy with autologous blood stem cell transplantation in multiple myeloma. Results of a phase II trial involving 63 patients. Blood 1993; 82: 2005–2009
   PubMed Web of Science ®Google Scholar
• Vesole D. H., Barlogie B., Jagannath S., Cheson B., Tricot G., Alexanian R., Crowley J. High-dose therapy for refractory multiple mycloina: Improved prognosis with better supportive care and double transplant. Blood 1994; 84: 950–956
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichstentein A. Evidence of peripheral blood B-lymphocyte but not T-lymphocyte involveincut in multiple myeloma. Blood 1987; 70: 1550–1564
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Jensen G. S. Monoclonal circulating B-cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/ Oncology Clinics of North America 1992; 6: 297–322
   PubMed Web of Science ®Google Scholar
• Bergui L., Schena M., Gaidano C. L., Riva M., Caligaris-Cappio F. Interleukin 3 and Interlcukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 1989; 170: 613–618
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Belch A. R. Circulating monoclonal B cells expressing P glyooprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 1994; 83: 724–736
   PubMed Web of Science ®Google Scholar
• Cavo M., Benni M., Cirio T. M., Gozzetti A., Tura S. Allogeneic hone marrow transplantation for the treatment of multiple myeloma. An overview of published reports. Stem Cells 1995; 13(suppl. 2)126–131
   PubMedGoogle Scholar
• Tricot G., Vesole D. H., Jagannath S., Hilton J., Munshi N., Barlogie B. Graft-versus-myeloma effect: Proof of principle. Blood 1996; 87: 1196–1198
   PubMed Web of Science ®Google Scholar
• Brenner M. K., Rill D. R., Moen R. C., Krance R. A., Mirro J., French Anderson W., Ihle J. N. Gene-marking to trace the origin of relapse agter autologous bone-marrow transplantation. Lancet 1993; 341: 85–86
   PubMed Web of Science ®Google Scholar
• Lemoli R. M., Fortuna A., Motta M. R., Rizzi S., Giudice V., Nannetti A., Martinelli G., Cavo M., Amabile M., Mangianti S., Fogli M., Conte R., Tura S. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: Positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 1996; 87: 1625–1634
   PubMed Web of Science ®Google Scholar
• Benini C., Bandini G., Motta M. R., Belardinelli A. R., Calori E., Rizzi S., Martinelli G., Rosti G., Trabetti E., Pignatti P., Tura S. Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow. Haematologica 1993; 78: 414–415
   PubMedGoogle Scholar
• Lemoli R. M., Gasparetto C., Scheinherg D. A., Moore M. A. S., Clarkson B. D., Gulati S. C. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with niyeloid-specific monoclonal antibodies and drugs in combination. Blood 1991; 77: 1829–1836
   PubMed Web of Science ®Google Scholar
• Lemoli R. M., Fortuna A., Grande A., Gamberi B., Bonsi L., Fogli M., Amabile M., Cavo M., Ferari S., Tura S. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma. Br J Haematol 1994; 88: 760–769
   PubMed Web of Science ®Google Scholar
• Schiller G. J., Vescio R. A., Freytes C., Spitzer G., Sahebi F., Lee M., Hua C., Cao J., Lee J. C., Hong C. H., Bearnian S., Lill M., Berenson R., Berenson J. Transplantation of CD34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390–397
   PubMed Web of Science ®Google Scholar
• Brisco M. J., Tan L. W., Orsborn A. M., Morley A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 1990; 75: 163–167
   PubMed Web of Science ®Google Scholar
• Martinelli G., Buzzi M., Zaccaria A., Mantovani V., Farabegoli P., Calori E., Bandini G., Bragliani M., Barboni P., Panzica G., Tura S. New strategies for selection of unrelated bone marrow donors. Bone Marrow Transplantation 1993; 11: 31–32
   PubMed Web of Science ®Google Scholar
• Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992; 227: 776–781
   PubMed Web of Science ®Google Scholar
• Ravetech J. V., Siebenlist U., Korsmeyer S., Waldman T., Leder P. Structure of the human iminunoglobulin locus: characterisation of embrionic and rearranged J and D genes. Cell 1981; 27: 583–591
   PubMed Web of Science ®Google Scholar
• Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237
   PubMed Web of Science ®Google Scholar
• Gianni A. M., Bregni M., Stern A., Siena S., Tarella C., Pileri A., Bonadonna G. Granulocyte-macro-phage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; ii: 580–584
   Google Scholar
• Deisserolh A. B., Zu Z., Claxton D., Hanania E. G., Fu S., Ellerson D., Goldberg L., Thomas M., Janicek K., French Anderson W., Hester J., Korbling M., Durett A., Moen R., Berenson R., Heimfeld S., Hamer J., Calvert L., Tihbits P., Talpaz M., Kantarjian H., Champlin R., Reading C. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068–3076
   PubMed Web of Science ®Google Scholar
• Carlo Stella C., Cazzola M., De Fabritiis P., De Vincentiis A., Gianni A. M., Lanza F., Lauria F., Lemoli R. M., Tarella C., Zanon P., Tura S. CD34-Positive cells: Biology and clinical relevance. Haematologica 1995; 80: 367–387
   PubMedGoogle Scholar
• Berenson R. J., Bensinger W. I., Andrews R. G., Kalamasz D., Hill R., Bernstcin I. D. Hematopoietic stem cell transplants. Recent advances in leukemia and lymphoma, R. P. Gale, D. W. Golde. Wiley-Liss, New York 1987; vol. 61: 527, UCLA Symposia on molecular and cellular biology, New Series
   Google Scholar
• Watt S. M., Karhi K., Gatter K., Furley A. J. W., Katz F. E., Healy L. E., Altass L. J., Bradley N. J., Sutherland D. R., Levinsky R., Greaves M. F. Distribution and epitope analysis of the cell inemhrane glycoprotein (HPCA-I) associated with human hematopoietic progenitor cells. Leukemia 1988; 1: 417–424
   Web of Science ®Google Scholar
• Takishita M., Kosaka M., Goto T., Saito S. Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. Br J Haematol 1994; 87: 735–742
   PubMed Web of Science ®Google Scholar
• Sahota S., Hamblin T., Oscier D. G., Stevenson F. K. Assessment of the role of clonogenic B-lymphocytes in the pathogenesis of multiple myeloma. Leakemia 1994; 8: 1285–1289
   PubMed Web of Science ®Google Scholar
• Vescio R. A., Hong C. H., Cao J., Kim A., Schiller G. J., Lichtenstein A. K., Berenson R. J., Berenson J. R. The hematopoietic stem cell antigen, CD34 is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283–3290
   PubMed Web of Science ®Google Scholar
• Gazitt Y., Reading C., Hoffman R., Wickrema A., Vesole D. H., Jagannath S., Condino J., Lee B., Barlogie B., Tricot G. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381–389
   PubMed Web of Science ®Google Scholar
• Lemoli R. M., Tazzari P. L., Fortuna A., Bolognesi A., Gulati S. C., Stirpe F., Tura S. Positive selection of hematopoietic CD34+ stem cells provides “indirect purging” of CD34-- lymphoid cells and the purging efficiency is increased by antiLCD2 and anti-CD30 immunotoxins. Bone Marrow Transplantation 1994; 13: 465–471
   PubMed Web of Science ®Google Scholar
• Gobbi M., Cavo M., Tazzari P. L., Dinota A., Tassi C., Bontadini A., Albertazzi L., Miggiano M. C., Rizzi S., Rosti G., Bolognesi A., Stirpe F., Tura S. Autologous hone marrow transplantation with immunotoxinpurged marrow for advanced multiple myeloma. Eur J Haematol 1989; 43(Suppl. 51)176–181
   Google Scholar